J Gregory Dolan (Joseph G Dolan)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Peripheral Blood

Top Venues

Pediatric blood & cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Lori S Muffly, Emily C Liang, J Gregory Dolan, Michael A Pulsipher
How I use next-generation sequencing-MRD to plan approach and prevent relapse after HCT for children and adults with ALL. Blood 144 (3) (2024)
Lori S Muffly, Emily C Liang, J Gregory Dolan, Michael A Pulsipher
How I Use Next Generation Sequencing-MRD to Plan Approach and Prevent Relapse after HCT for Children and Adults with ALL. Blood (2024)
Lori S Muffly, Emily C Liang, J Gregory Dolan, Michael A Pulsipher
How I use next-generation sequencing-MRD to plan approach and prevent relapse after HCT for children and adults with ALL. Blood 144 (3) (2024)
Lori S Muffly, Emily C Liang, J Gregory Dolan, Michael A Pulsipher
How I use next-generation sequencing-MRD to plan approach and prevent relapse after HCT for children and adults with ALL. Blood 144 (3) (2024)
J Gregory Dolan, Douglas L Hill, Laura Palmer, Chris Feudtner
Addressing spiritual distress in pediatric oncology. Pediatric blood & cancer 69 (3) (2022)
J Gregory Dolan, Douglas L Hill, Jennifer A Faerber, Laura E Palmer, Lamia P Barakat, Chris Feudtner
Association of psychological distress and religious coping tendencies in parents of children recently diagnosed with cancer: A cross-sectional study. Pediatric blood & cancer 68 (7) (2021)
Stephan Kadauke, Regina M Myers, Yimei Li, Richard Aplenc, Diane Baniewicz, David M Barrett, Allison Barz Leahy, Colleen Callahan, J Gregory Dolan, Julie C Fitzgerald, Whitney Gladney, Simon F Lacey, Hongyan Liu, Shannon L Maude, Regina McGuire, Laura S Motley, David Trent Teachey, Gerald B Wertheim, Lisa Wray, Amanda M DiNofia, Stephan A Grupp
Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (8) (2021)